Tech Company Financing Transactions

Armo Bio Sciences Funding Round

Armo Bio Sciences closed a $30 million Series B funding round on 5/28/2014. Investors included NanoDimension, DAG Ventures and Kleiner Perkins Caufield & Byers.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B

NanoDimension (Lead Investor)

DAG Ventures

Kleiner Perkins Caufield & Byers (Beth Seidenberg)

OrbiMed (Carl Gordon)

Proceeds Purpose
We intend to use the Series B funding to complete several expansion cohorts of our Phase 1 study of AM0010, including drug combination cohorts designed to evaluate the safety and tolerability of AM0010 in combination with standard of care and with other immunotherapy drugs. We expect results from the dose escalation part of the study by mid-2014.

Company Information

Company Status
Private & Independent
Mailing Address
575 Chesapeake Dr.
Redwood City, CA 94063
Email Address
ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.
Armo Bio Sciences LinkedIn Company Profile
Social Media
Armo Bio Sciences Company Twitter Account
Company News
Armo Bio Sciences News
Armo Bio Sciences on Facebook
Armo Bio Sciences on YouTube

Management Team

Email & Social
Chief Executive Officer
Peter Van Vlasselaer
  Peter Van Vlasselaer LinkedIn Profile  Peter Van Vlasselaer Twitter Account  Peter Van Vlasselaer News  Peter Van Vlasselaer on Facebook
Chief Medical Officer
Joseph Leveque
  Joseph Leveque LinkedIn Profile  Joseph Leveque Twitter Account  Joseph Leveque News  Joseph Leveque on Facebook
Martin Oft
  Martin Oft LinkedIn Profile  Martin Oft Twitter Account  Martin Oft News  Martin Oft on Facebook
VP - Bus. Development
Scott Ogg
  Scott Ogg LinkedIn Profile  Scott Ogg Twitter Account  Scott Ogg News  Scott Ogg on Facebook
VP - Operations
Russell Kawahata
  Russell Kawahata LinkedIn Profile  Russell Kawahata Twitter Account  Russell Kawahata News  Russell Kawahata on Facebook



Browse more venture capital transactions:

Prev: 5/28/2014: Distil Networks venture capital transaction
Next: 5/28/2014: MedCPU venture capital transaction


Share this article


News on VC Transactions

Our team works diligently to document every notable VC transaction. VC transactions on this site come from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary